A study for a 18 year old girl who takes Malarone Pediatric - from FDA reports
121 females aged 18 (±5) who take the same drug are studied. This is a personalized study for a 18 year old female patient who has Malaria Prophylaxis. The study is created by eHealthMe based on reports from FDA.
Personalized health information
On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>
On Mar, 20, 2017
121 females aged 18 (±5) who takes Malarone Pediatric are studied.
Number of reports submitted per year:
Information of the patient in this study:
- Age: 18
- Gender: female
- Conditions: Malaria Prophylaxis
- Drugs taken:
- Malarone Pediatric (atovaquone; proguanil hydrochloride)
- Side effects: Rash
eHealthMe real world results:
Comparison with this patient's adverse outcomes:
- Rash: 2 (1.65% of females aged 18 (±5) who take the drug)
As an adverse outcome could be a symptom of a condition, additional studies are listed to help identify the cause: for example, regardless of which drug is taken, how many female HBP patients aged 50 (±5) have nausea
- Rash in Malaria Prophylaxis: 7 (3.15% of females aged 18 (±5) who have Malaria Prophylaxis)
As an adverse outcome could be a side effect of a drug, additional studies are listed to help identify the cause: for example, how many female Aspirin users aged 50 (±5) have nausea
- Rash in Malarone Pediatric: 2 (1.65% of females aged 18 (±5) who take Malarone Pediatric)
Top conditions involved for these people *:
- Malaria (72 people, 59.50%)
- Preventive Health Care (5 people, 4.13%)
- Birth Control (5 people, 4.13%)
- Plasmodium Falciparum Infection (4 people, 3.31%)
- Infection Parasitic (2 people, 1.65%)
Top co-used drugs for these people *:
- Lariam (5 people, 4.13%)
- Yaz (4 people, 3.31%)
- Yasmin (4 people, 3.31%)
- Norfloxacin (3 people, 2.48%)
- Lamictal (2 people, 1.65%)
Top other side effects for these people *:
- Fever (13 people, 10.74%)
- Drug Ineffective (13 people, 10.74%)
- Diarrhea (13 people, 10.74%)
- Malaria (10 people, 8.26%)
- Fatigue (10 people, 8.26%)
* Some reports may have incomplete information.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
You can also:
What are the drugs?
- Malarone pediatric has active ingredients of atovaquone; proguanil hydrochloride. (latest outcomes from Malarone pediatric 2 users)
What are the conditions?
- Malaria prophylaxis can be treated by Malarone, Doxycycline, Doxycycline hyclate, Lariam, Mefloquine (latest reports from 4,179 Malaria prophylaxis patients)
What are the symptoms?
- Rash has been reported by people with rheumatoid arthritis, high blood pressure, hepatitis c, multiple sclerosis, high blood cholesterol (latest reports from 263,438 Rash patients).
Could your drugs cause:
Could your conditions cause:
Can you answer these questions?
I started taking 600 mg twice. After a week started mild rash like heat pricks. Saw the Dr after a month. Used hydrocortizone. No change. Now it I s getting worsen. Specially in legs and back. I just thought only medication Inew was Lopid. I am going to stop today. Please let me know this ...
You may be interested in these reviews
I stared nexplanon on 3/16/17 and yesterday 3/17/17 I woke up with a rash on my checks I just wonder if this is a side effect of this birth control? I went to the emergency room they told me is dermatitis...
I am a male in my 70's and have been using the Neupro patch daily for 10 years (many years RX from Europe) for RLS. About 2 months ago a red rash started to appear that itches and takes a long time to heal. What can I do other than using lotion? Thanks!
Hello everyone. I'm desperate to find a doctor who really understands lamictal rash in CO preferably. I was diagnosed by my neurologist this week but have been suffering and home bound since Halloween. 4 dermatologist and a hospital that diagnosed me with all kinds of crazy stuff that wasn't ...